Invention Grant
- Patent Title: Method for purifying PEGylated erythropoietin
-
Application No.: US17145653Application Date: 2021-01-11
-
Publication No.: US11993630B2Publication Date: 2024-05-28
- Inventor: Roberto Falkenstein , Bernhard Spensberger
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: HOFFMANN-LA ROCHE INC
- Current Assignee: HOFFMANN-LA ROCHE INC
- Current Assignee Address: US NJ Little Falls
- Agent Charles Wong
- Priority: EP 179755 2016.07.15
- Main IPC: C07K1/16
- IPC: C07K1/16 ; B01D15/26 ; B01D15/36 ; C07K1/18 ; C07K14/505

Abstract:
Herein is reported a method for the purification of a protein comprising erythropoietin and a single poly (ethylene glycol) residue from reaction by-products or not reacted starting material by a cation exchange chromatography method. It has been found that by employing a cation exchange Toyopearl® SP-650 chromatography material and employing a second wash step with an increased pH value compared to the first wash step a fusion protein of erythropoietin and a single poly (ethylene glycol) residue can be obtained in a single step with high purity and yield and suitability for large scale applications.
Public/Granted literature
- US20210155655A1 Method for purifying PEGylated erythropoietin Public/Granted day:2021-05-27
Information query